• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Dr Veena Shankaran Discusses Patient-Level Cancer Economics

Article

Most of the research in cancer economics has been on total cost and cost effectiveness, which is why Veena Shankaran MD, MS, assistant professor in the division of medical oncology at the University of Washington, wanted to have a panel discussion on financial toxicity at the ISPOR 20th Annual Meeting.

Most of the research in cancer economics has been on total cost and cost effectiveness, which is why Veena Shankaran MD, MS, assistant professor in the division of medical oncology at the University of Washington, wanted to have a panel discussion on financial toxicity at the ISPOR 20th Annual Meeting.

The goal of the talk was to present strategies to measure financial burden and how to decrease the financial burden.

Related Videos
Nihar Desai, MD, MPH
Dr Toon Van Gorp
Andrew Kuykendall, MD, Moffitt Cancer Center
Leigh Maria Ramos-Platt, MD
Elizabeth Jones, MD, FAAD
Barry Byrne, MD
Giulio Cossu, MD
Dr Toon Van Gorp
Frederick L. Locke, MD, Moffitt Cancer Center and Research Institute
Related Content
© 2025 MJH Life Sciences
AJMC®
All rights reserved.